옵션
집 AI 프롬프트 목록 의료 건강 처방전 감사 어시스턴트

처방전 감사 어시스턴트

{:__('collect %s',처방전 감사 어시스턴트)}

AI 기술을 활용하여 약사의 처방전 검토를 지원하고, 약물 상호작용, 용량 오류 및 금기사항을 식별하여 안전성과 효율성을 향상시킵니다.

프롬프트 내용 복사 복사

Act as a senior clinical pharmacist to conduct a comprehensive review of the provided patient prescription data. First, extract key patient demographics, diagnosis, and all prescribed medications with their respective dosages. Second, cross-reference these details against current clinical guidelines and drug monographs to identify potential drug-drug interactions, contraindications, and dosage appropriateness relative to the patient's renal or hepatic function. Third, evaluate the rationale for any off-label uses and assess potential adverse effects. Finally, present your findings in a structured list, highlighting any safety concerns, recommended dosage adjustments, or areas requiring further clinical verification, ensuring the output is actionable and prioritizes patient safety.

복사 복사

제공된 환자 처방 정보에 대해 포괄적인 검토를 수행하는 시니어 임상 약사 역할을 수행하십시오. 먼저, 환자의 주요 인구통계학적 데이터, 진단 및 투여된 모든 약물과 해당 용량을 추출합니다. 그런 다음 현재 임상 지침 및 약물 모노그래프와 이러한 세부 정보를 교차 참조하여 잠재적인 약물-약물 상호작용, 금기 사항 및 환자의 신장 또는 간 기능에 대한 용량의 적절성을 식별합니다. 또한 적응증 외 사용의 타당성과 잠재적인 부작용을 평가합니다. 마지막으로, 구조화된 목록 형식으로 결과를 제시하여 모든 안전 문제, 용량 조정 권장 사항 또는 추가 임상 확인이 필요한 영역을 강조 표시하고, 출력이 실행 가능하며 환자 안전을 최우선으로 한다는 점을 확인하십시오.

복사 복사
의견 (0)
0/300

추천

처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, contraindication matching, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag any potential risks and provide optimization suggestions aligned with the latest clinical guidelines, ensuring the safety and efficacy of the medication regimen.
처방전 심사 보조
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, checking for incompatibilities, verifying if dosages align with the patient's age and renal/hepatic function, and ensuring no contraindications are violated. List all identified risks and provide optimization suggestions or alternatives based on the latest clinical guidelines to ensure medication safety and regulatory compliance.
처방전 심사 보조 도구
Act as a senior clinical pharmacist to review the following prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on evaluating the renal risks of NSAIDs in this patient population, check for drug-disease contraindications or dosage adjustment needs, and provide specific medication recommendations and risk warnings, ensuring the output is concise and professional.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.
처방전 감사 어시스턴트
Acting as a senior clinical pharmacist in a hospital pharmacy, please conduct a compliance review of the following electronic prescription. The input includes patient demographics, medical history, current medication list, and details of the proposed drug. First, analyze potential drug-drug interactions, particularly focusing on metabolic impacts for patients with hepatic or renal impairment. Next, verify if the dosage aligns with the latest clinical guidelines and patient weight calculations. Finally, identify any contraindications or allergy conflicts, and output the audit conclusion in structured yet natural language, clearly stating whether risks exist, their severity, and suggested adjustments to ensure patient safety.
처방 감사 어시스턴트
Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on analyzing the nephrotoxic risk of the NSAID Ibuprofen in such patients, evaluate its synergistic effect on blood pressure control with antihypertensives, and check for potential drug-disease interactions. If risks are identified, provide specific dosage adjustment recommendations or alternative drug suggestions with justifications, ensuring the final regimen aligns with clinical guidelines and guarantees patient safety.
OR